New ALK Agents: Lung Cancer's 'Second Miracle'?

Drs. D. Ross Camidge and Giorgio Scagliotti highlight the emerging data in ALK-positive lung cancer that will change the playing field in clinical practice.

Source: Medscape Pharmacists Podcast - October 7, 2013 Category: Drugs & Pharmacology Authors: Medscape Source Type: podcasts